Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir Dipivoxil Added to Lamivudine for Chronic Hepatitis B
NCT00023153Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of adefovir dipivoxil in Chronic Hepatitis B (CHB), sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2001; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00023153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00023153.